FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384206969> ?p ?o ?g. }

• W4384206969 endingPage "107362" @default.
• W4384206969 startingPage "107362" @default.
• W4384206969 abstract "One of the major concerns with post-acute sequelae of COVID-19 (PASC) is the development of pulmonary fibrosis, for which no approved pharmacological treatment exists. Therefore, the primary aim of this open-label study was to evaluate the safety and the potential clinical efficacy of a prolonged-release pirfenidone formulation (PR-PFD) in patients having PASC-pulmonary fibrosis.Patients with PASC-pulmonary fibrosis received PR-PFD 1800 mg/day (1200 mg in the morning after breakfast and 600 mg in the evening after dinner) for three months. Blood samples were taken to confirm the pharmacokinetics of PR-PFD, and adverse events (AEs) were evaluated monthly using a short questionnaire. Symptoms, dyspnea, and pulmonary function tests (spirometry, diffusing capacity for carbon monoxide, plethysmography, and 6-min walk test [6MWT]) were evaluated at baseline, and one and three months after having started the PR-PFD treatment.Seventy subjects with mild to moderate lung restriction were included. The most common AEs were diarrhea (23%), heartburn (23%), and headache (16%), for which no modifications in the drug study were needed. Two patients died within the first 30 days of enrolment, and three opted not to continue the study, events which were not associate with PR-PFD. Pulmonary function testing, 6MWT, dyspnea, symptoms, and CT scan significantly improved after three months of treatment with PR-PFD.In patients with PASC pulmonary fibrosis, three months' treatment with PR-PFD was safe and showed therapeutic efficacy. Still, it remains to be seen whether the pulmonary fibrotic process remains stable, becomes progressive or will improve." @default.
• W4384206969 created "2023-07-14" @default.
• W4384206969 creator A5011241778 @default.
• W4384206969 creator A5020143656 @default.
• W4384206969 creator A5024763540 @default.
• W4384206969 creator A5028368413 @default.
• W4384206969 creator A5032660814 @default.
• W4384206969 creator A5045523078 @default.
• W4384206969 creator A5060089859 @default.
• W4384206969 creator A5062823961 @default.
• W4384206969 creator A5071018778 @default.
• W4384206969 creator A5082548896 @default.
• W4384206969 creator A5090940412 @default.
• W4384206969 creator A5092464836 @default.
• W4384206969 creator A5092464837 @default.
• W4384206969 creator A5092464838 @default.
• W4384206969 date "2023-10-01" @default.
• W4384206969 modified "2023-09-27" @default.
• W4384206969 title "Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy" @default.
• W4384206969 cites W1978349722 @default.
• W4384206969 cites W2037557484 @default.
• W4384206969 cites W2097734747 @default.
• W4384206969 cites W2101548854 @default.
• W4384206969 cites W2118894860 @default.
• W4384206969 cites W2135112559 @default.
• W4384206969 cites W2510153066 @default.
• W4384206969 cites W2606007227 @default.
• W4384206969 cites W2774138788 @default.
• W4384206969 cites W2975597462 @default.
• W4384206969 cites W3002376302 @default.
• W4384206969 cites W3025232799 @default.
• W4384206969 cites W3035947417 @default.
• W4384206969 cites W3041493976 @default.
• W4384206969 cites W3044231852 @default.
• W4384206969 cites W3044956284 @default.
• W4384206969 cites W3048127866 @default.
• W4384206969 cites W3094572524 @default.
• W4384206969 cites W3112786508 @default.
• W4384206969 cites W3133517424 @default.
• W4384206969 cites W3136905534 @default.
• W4384206969 cites W3159231251 @default.
• W4384206969 cites W3165269354 @default.
• W4384206969 cites W3184339862 @default.
• W4384206969 cites W3193393853 @default.
• W4384206969 cites W3201938605 @default.
• W4384206969 cites W3212002855 @default.
• W4384206969 cites W4200621793 @default.
• W4384206969 cites W4212847828 @default.
• W4384206969 cites W4214586694 @default.
• W4384206969 cites W4220918605 @default.
• W4384206969 cites W4225572281 @default.
• W4384206969 cites W4226016748 @default.
• W4384206969 cites W4283075427 @default.
• W4384206969 cites W4293802328 @default.
• W4384206969 cites W4294732834 @default.
• W4384206969 cites W4310595140 @default.
• W4384206969 cites W4316014106 @default.
• W4384206969 cites W4381548408 @default.
• W4384206969 doi "https://doi.org/10.1016/j.rmed.2023.107362" @default.
• W4384206969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37451648" @default.
• W4384206969 hasPublicationYear "2023" @default.
• W4384206969 type Work @default.
• W4384206969 citedByCount "0" @default.
• W4384206969 crossrefType "journal-article" @default.
• W4384206969 hasAuthorship W4384206969A5011241778 @default.
• W4384206969 hasAuthorship W4384206969A5020143656 @default.
• W4384206969 hasAuthorship W4384206969A5024763540 @default.
• W4384206969 hasAuthorship W4384206969A5028368413 @default.
• W4384206969 hasAuthorship W4384206969A5032660814 @default.
• W4384206969 hasAuthorship W4384206969A5045523078 @default.
• W4384206969 hasAuthorship W4384206969A5060089859 @default.
• W4384206969 hasAuthorship W4384206969A5062823961 @default.
• W4384206969 hasAuthorship W4384206969A5071018778 @default.
• W4384206969 hasAuthorship W4384206969A5082548896 @default.
• W4384206969 hasAuthorship W4384206969A5090940412 @default.
• W4384206969 hasAuthorship W4384206969A5092464836 @default.
• W4384206969 hasAuthorship W4384206969A5092464837 @default.
• W4384206969 hasAuthorship W4384206969A5092464838 @default.
• W4384206969 hasConcept C126322002 @default.
• W4384206969 hasConcept C165637977 @default.
• W4384206969 hasConcept C197934379 @default.
• W4384206969 hasConcept C2776042228 @default.
• W4384206969 hasConcept C2777714996 @default.
• W4384206969 hasConcept C2777914695 @default.
• W4384206969 hasConcept C2778341716 @default.
• W4384206969 hasConcept C2779832356 @default.
• W4384206969 hasConcept C2780333948 @default.
• W4384206969 hasConcept C2781244666 @default.
• W4384206969 hasConcept C3018587741 @default.
• W4384206969 hasConcept C55520419 @default.
• W4384206969 hasConcept C71924100 @default.
• W4384206969 hasConcept C75603125 @default.
• W4384206969 hasConceptScore W4384206969C126322002 @default.
• W4384206969 hasConceptScore W4384206969C165637977 @default.
• W4384206969 hasConceptScore W4384206969C197934379 @default.
• W4384206969 hasConceptScore W4384206969C2776042228 @default.
• W4384206969 hasConceptScore W4384206969C2777714996 @default.
• W4384206969 hasConceptScore W4384206969C2777914695 @default.

• next